New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BMY;STRA;JNJ;IQNT;HES;VNO;NKTR;JCP;CAT;PBR;VRTX;KRC;GRMN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
March 17, 2015
11:31 EDTCATCaterpillar sees up year for North American construction
Sees some competitors in the construction segment becoming more price competitive.
11:10 EDTCATCaterpillar says balance sheet will allow M&A for potential targets
Says metrics are in "great shape." Says not afraid of doing a "multi-billion dollar" deal.
11:05 EDTCATCaterpillar seeing some activity in domestic infrastructure investment
Comments from Caterpillar at Bank of American Merrill Lynch Global Industrials Conference.
10:44 EDTCATCaterpillar reaffirms FY15 EPS ex-items about $4.75, consensus $4.74
Subscribe for More Information
06:57 EDTJCPJ.C. Penney CMO leaves company, effective immediately, AdAge reports
Subscribe for More Information
05:35 EDTJNJJohnson & Johnson to invest $10M in UK government fund to fight dementia
Subscribe for More Information
March 16, 2015
15:04 EDTJNJPharmacyclics says committee recommends unblinding after primary endpoint met
Subscribe for More Information
10:02 EDTGRMNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:28 EDTGRMNGarmin downgraded at Oppenheimer
Subscribe for More Information
06:40 EDTGRMNGarmin downgraded to Perform from Outperform at Oppenheimer
March 13, 2015
16:28 EDTHESWhiting attracts interest from Exxon Mobil, Hess, Continental, Bloomberg says
Subscribe for More Information
16:01 EDTPBROptions Update; March 13, 2015
Subscribe for More Information
15:54 EDTHESWhiting attracts interest from Exxon Mobil, Hess, Continental, Bloomberg says
Subscribe for More Information
14:34 EDTJNJU.S. appeals court revives lawsuit over J&J's Benecol assertions
Subscribe for More Information
13:04 EDTNKTRFly Watch: Nektar breast cancer data expected soon
Subscribe for More Information
11:19 EDTVRTXBioMarin rallies amid positive call on DMD drug timeline, takeover rumor
The shares of drug maker BioMarin (BMRN) are climbing after research firm Jefferies quoted a regulatory expert as saying that the company's drisapersen drug has a good chance of being approved on an accelerated basis by the FDA. Drisapersen is a treatment for Duchenne Muscular Dystrophy, or DMD. WHAT'S NEW: "There is a strong possibility" that the FDA will grant accelerated approval to drisapersen because there is currently no approved drug for the treatment of DMD, Jefferies analyst Eun Yang quoted the expert as saying. The expert is also optimistic about the outlook for accelerated approval because she had a good experience working with BioMarin while she was with the FDA and because BioMarin has a favorable track record with the FDA, according to Yang. There is a 60% chance that drisapersen will be approved by the end of this year and the stock can rise to $155, versus its current level of about $121.50, if that does occur, the analyst stated. Yang's price target on the stock increased to $135 from $125 and the analyst kept a Buy rating on the shares. WHAT'S NOTABLE: Pharmaceutical giant AstraZeneca (AZN) has been rumored to be interested in buying BioMarin for $175 per share in cash, British newspaper Daily Mail reported. , Piper Jaffray analyst Joshua Schimmer wrote in a note to investors this morning that BioMarin, along with Vertex (VRTX) and Incyte (INCY), have a "clear path" to joining the group of companies with market caps of over $10B projected to deliver greater than 20% EPS CAGR, which the analyst identified as a set of criteria that has previously pointed to companies that make good potential takeover targets. PRICE ACTION: In mid-morning trading, BioMarin climbed nearly 4% to $120.
09:50 EDTPBRActive equity options trading on open
Subscribe for More Information
09:28 EDTPBRPetrobras seeks deadline deal with creditors, Folha reports
Subscribe for More Information
07:23 EDTJNJJohnson & Johnson has a conference call hosted by JPMorgan
Subscribe for More Information
05:56 EDTPBRStocks with implied volatility movement; MYL PBR
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use